<DOC>
	<DOCNO>NCT02035267</DOCNO>
	<brief_summary>The objective study explore safety efficacy subcutaneous injection ATX-101 relative placebo , submental area .</brief_summary>
	<brief_title>Safety Study ATX-101 Subjects With Varying Chin Sizes</brief_title>
	<detailed_description />
	<mesh_term>Deoxycholic Acid</mesh_term>
	<criteria>Male female subject , 18 65 year old Stable Body weight BMI ≤40.0 kg/m2 Acceptable volume submental fat grade clinician Dissatisfaction submental area express subject Signed inform consent form ( ICF ) No prior intervention SMF ( eg , liposuction , surgery , lipolytic agent ) Absence clinically significant health problem History intervention treat SMF ( eg , liposuction , surgery , lipolytic agent ) History trauma associate chin neck area judgment investigator may affect evaluation safety efficacy treatment Body mass index ≤40 kg/m2</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>